These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9207934)

  • 41. Solid-phase synthesis of tetrahydropyridazinedione-constrained peptides.
    Kang CW; Ranatunga S; Sarnowski MP; Del Valle JR
    Org Lett; 2014 Oct; 16(20):5434-7. PubMed ID: 25295511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caspase substrates and inhibitors.
    Poreba M; Strózyk A; Salvesen GS; Drag M
    Cold Spring Harb Perspect Biol; 2013 Aug; 5(8):a008680. PubMed ID: 23788633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and evaluation of unsaturated caprolactams as interleukin-1beta converting enzyme (ICE) inhibitors.
    Wang Y; O'Neil SV; Wos JA; Oppong KA; Laufersweiler MC; Soper DL; Ellis CD; Baize MW; Fancher AN; Lu W; Suchanek MK; Wang RL; Schwecke WP; Cruze CA; Buchalova M; Belkin M; De B; Demuth TP
    Bioorg Med Chem; 2007 Feb; 15(3):1311-22. PubMed ID: 17127070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An efficient stereoselective synthesis of [3S(1S,9S)]-3-[[[9-(benzoylamino) octahydro-6,10-dioxo-6H-pyridazino-(1,2-a)(1,2)-diazepin-1-yl]-carbonyl ]amino]-4-oxobutanoic acid, an interleukin converting enzyme (ICE) inhibitor.
    Chen MH; Goel OP; Hyun JW; Magano J; Rubin JR
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1587-92. PubMed ID: 10386941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Total synthesis of the interleukin-1beta converting enzyme inhibitor EI-1941-2 using tandem oxa-electrocyclization/oxidation1.
    Kleinke AS; Li C; Rabasso N; Porco JA
    Org Lett; 2006 Jun; 8(13):2847-50. PubMed ID: 16774272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.
    Dolle RE; Prasad CV; Prouty CP; Salvino JM; Awad MM; Schmidt SJ; Hoyer D; Ross TM; Graybill TL; Speier GJ; Uhl J; Miller BE; Helaszek CT; Ator MA
    J Med Chem; 1997 Jun; 40(13):1941-6. PubMed ID: 9207934
    [No Abstract]   [Full Text] [Related]  

  • 47. Pralnacasan (vertex pharmaceuticals).
    Siegmund B; Zeitz M
    IDrugs; 2003 Feb; 6(2):154-8. PubMed ID: 12789619
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.